Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small Cell Lung Cancer
- 1 July 2005
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 80 (1) , 268-275
- https://doi.org/10.1016/j.athoracsur.2005.02.005
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Sealing of the mediastinum with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non–small cell lung carcinomaThe Annals of Thoracic Surgery, 2004
- A randomized trial of systematic nodal dissection in resectable non-small cell lung cancerLung Cancer, 2002
- Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancerThe Annals of Thoracic Surgery, 2000
- Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: The role of systematic nodal dissectionLung Cancer, 1998
- EditorialThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Incidence of local recurrence and second primary tumors in resected stage I lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancerThe Annals of Thoracic Surgery, 1995
- Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: A randomized controlled trialBritish Journal of Surgery, 1994
- Role of systematic mediastinal dissection in N2 non-small cell lung cancer patientsThe Annals of Thoracic Surgery, 1993
- Mediastinal lymph node dissection in resected lung cancer: Morbidity and accuracy of stagingThe Annals of Thoracic Surgery, 1993